Small Molecules in Regenerative Medicine: Advancements, Applications, and Challenges

In regenerative medicine, small molecules have become extremely effective tools, providing potential approaches to support cell regeneration, tissue repair, and functional recovery in a range of illnesses. Because of their ability to alter important signaling pathways that control cell survival, proliferation, and differentiation, these compounds are excellent prospects for therapeutic uses. The efficacy of stem cell therapies, gene therapies, and tissue engineering may be improved by recent developments in small molecule-based treatments. Small molecules have opened the door for new methods in bone, cartilage, cardiac, and neuroregeneration by combining them with other regenerative technologies. Despite these developments, obstacles like cost, patient variability, and regulatory barriers still stand in the way of implementing small molecule-based treatments in clinical settings. The creation of tailored treatments, improved drug delivery methods, and the use of small molecules to treat more complicated illnesses are some potential future paths in this area. This review emphasizes how small compounds could revolutionize regenerative medicine and how they will influence future treatment approaches for tissue regeneration and repair.